Patent 7727277 was granted and assigned to Visioncare Ophthalmic Technologies on June, 2010 by the United States Patent and Trademark Office.
An artificial vision system including a sealed capsule adapted for intraocular placement upstream of a retina, an electronic display located within the sealed capsule and focusing optics located within the sealed capsule and arranged for focusing an image on the electronic display onto the retina.